Cost of treatment of oesophageal variceal bleeding in patients with cirrhosis in France: Results of a French survey

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 8, 2007, Pages 679-686

  Thabut, Dominique ^a   Hammer, Mette ^c   Cai, Yan ^c   Carbonell, Nicolas ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Bleeding; Child Pugh class; Cirrhosis; Cost of care; France; Oesophageal varices

Indexed keywords

OCREOTIDE; SOMATOSTATIN; TERLIPRESSIN; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ABDOMINAL PAIN; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG INDUCED HEADACHE; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FRANCE; GEOGRAPHIC DISTRIBUTION; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; INFORMATION PROCESSING; INTERVIEW; LIGATION; LIVER CIRRHOSIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT FAILURE; TREATMENT OUTCOME;

ESOPHAGEAL AND GASTRIC VARICES; FRANCE; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE SURVEYS; HEALTH SERVICES RESEARCH; HOSPITAL COSTS; HUMANS; LIVER CIRRHOSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34447555694     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3281bcb784     Document Type: Article

References (40)

1. Gow PJ, Chapman RW. Modern management of oesophageal varices. Postgrad Med J 2001; 77:75-81.
2. Cales P, Pascal JP. Natural history of esophageal varices in cirrhosis (from origin to rupture). Gastroenterol Clin Biol 1988; 12:245-254.
3. D'Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003; 124:1277-1291.
4. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40:652-659.
5. Lecleire S, Di Fiore F, Merle V, Herve S, Duhamel C, Rudelli A, et al. Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients: epidemiology and predictive factors of mortality in a prospective multicenter population-based study. J Clin Gastroenterol 2005; 39:321-327.
6. Brown DM, Everhart JE. Cost of digestive diseases in the United States. In: Everhart JE, editor. Digestive diseases in the United States: epidemiology and impact. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office; 1994: 3-53. NIH publication no. 94-1447.
7. Everhart JE. In: Everhart JE, ed. Digestive diseases in the United States: epidemiology and impact. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office; 1994: 57-82. NIH publication no. 94-1447.
8. Gralnek IM, Jensen DM, Kovacs TO, Jutabha R, Machicado GA, Gornbein J, et al. The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy. Hepatology 1999; 29:44-50.
9. Chung R, Lewis JW. Cost of treatment of bleeding esophageal varices. Arch Surg 1983; 118:482-485.
10. O'Donnell TF Jr, Gembarowicz RM, Callow AD, Pauker SG, Kelly JJ, Deterling RA. The economic impact of acute variceal bleeding: cost-effectiveness implications for medical and surgical therapy. Surgery 1980; 88:693-701.
11. Zaman A, Goldberg RJ, Pettit KG, Kaniecki DJ, Benner K, Zacker C, et al. Cost of treating an episode of variceal bleeding in a VA setting. Am J Gastroenterol 2000; 95:1323-1330.
12. Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J. Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ 1997; 315:510-514.
13. Rockall TA, Logan RF, Devlin HB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995; 311:222-226.
14. Vreeburg EM, Snel P, de Bruijne JW, Bartelsman JF, Rauws EA, Tytgat GN. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol 1997; 92:236-243.
15. Combier E, Levacher S, Letoumelin P, Joseph A, Pourriat JL, de PG. Cost-effectiveness analysis of the terlipressin-glycerin trinitrate combination in the pre-hospital management of acute gastro-intestinal haemorrhage in cirrhotic patients. Intensive Care Med 1999; 25:364-370.
16. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80:800-809.
17. Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. French Club for the Study of Portal Hypertension. N Engl J Med 2001; 344:23-28.
18. Patch D, Dagher L. Acute variceal bleeding: general management. World J Gastroenterol 2001; 7:466-475.
19. de Franchis R. Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. London: Blackwell Science Ltd; 1996.
20. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43:167-176.
21. de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992; 15:256-261.
22. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33:846-852.
23. Brenner E. WGO-OMGE Practice Guideline: Treatment of Esophageal Varices, 2003.
24. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2000; 46 (Suppl 3-4):III1-III15.
25. Lebrec D, Vinel JP, Dupas JL. Complications of portal hypertension in adults: a French consensus. Eur J Gastroenterol Hepatol 2005; 17:403-410.
26. Conseil National de l'Ordre des Médecins. Annuaire des médecins spécialistes en gastro-entérologie et/ou en hépatologie en exercice. 2005.
27. Le Répertoire Offisemp. Editions du Vidal. Edition numéro 2; 2004 May.
28. Pharm'index, le répertoire administratif et économique. Editions du Vidal. Edition numéro 2; 2005 Aug.
29. Les rémunérations dans les établissements de santé évolutions et comparaisons sur l'ensemble du secteur hospitalier entre 1999 et 2002. Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques (DREES). 2005.
30. Tarifs conventionnels des médecins généralistes; tarifs en euros à compter du 1er juillet 2005; Caisse Nationale d'Assurance Maladie. 22 August 2005.
31. Tarifs conventionnels des médecins spécialistes; Caisse Nationale d'Assurance Maladie. 9 December 2005.
32. Classification Commune des Actes Médicaux (CCAM); Caisse Nationale d'Assurance Maladie des Travailleurs Salariés (CNAMTS). Version 2. 2005 Sep.
33. Table nationale de codage de biologie, Nomenclature des Actes de Biologie Médicale (NABM); base de reference, version 21. 14 November 2005.
34. Arrêté du 10 Février 2004 modifiant l'arrêté du 23 Décembre 1997 modifié relatif au tarif de cession des produits sanguins labiles; Journal Officiel de la République Française. NOR: SANPO420350A; 2975-2976. 2004.
35. Centre hospitalier du pays d'aix. Prix des journées d'hospitalisation. 2004.
36. Czernichow P, Hochain P, Nousbaum JB, Raymond JM, Rudelli A, Dupas JL, et al. Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol 2000; 12:175-181.
37. Di Fiore F, Lecleire S, Merle V, Herve S, Duhamel C, Dupas JL, et al. Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol Hepatol 2005; 17:641-647.
38. Rolland N, Grandbastien B, Merle V, Gower-Rousseau C, Yzet T, Marti R, et al. Cost of early management of chronic inflammatory intestinal disease. Gastroenterol Clin Biol 1999; 23:483-488.
39. Selke B, Durand I, Marissal JP, Chevalier D, Lebrun T. Cost of colorectal cancer in France in 1999. Gastroenterol Clin Biol 2003; 27:22-27.
40. Jairath N, Weinstein J. The Delphi methodology (Part one): a useful administrative approach. Can J Nurs Adm 1994; 7:29-42.